DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Cannon CP, McGuire DK, Pratley R. et al.
VERTIS-CV Investigators. Design and baseline characteristics of the evaluation of ertugliflozin efficacy and Safety CardioVascular outcomes trial (VERTIS-CV).
Am Heart J 2018;
206: 11-23
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.